Overview
Cervicogenic headache (CBH) is defined as a headache caused by a disorder in the cervical spine, bones, discs, or soft tissue elements, which is also accompanied by neck pain.
Unilateral, non-reversible oculo, fronto, temporal pain, pain that increases with poor neck positioning and incorrect neck movements, and may be seen with restricted movement in the upper cervical and occiput regions.
The aim of this thesis is to compare the effectiveness of Mulligan mobilization technique and myofascial release methods used in the treatment of cervicogenic headache through a prospective clinical study.
Description
This study is designed as a prospective, case-control, hospital-based study. Ninety patients aged 18-65 years who present to our hospital with cervicogenic headaches lasting at least 3 months will be included in the study.
Participants will be given full information about the procedure and will provide written informed consent.
The study will be conducted in accordance with the principles outlined in the Helsinki Declaration.
All participants will undergo a comprehensive medical history and a detailed physical examination.
Sociodemographic and clinical data, including age, gender, height, weight, education level, employment status, and income level, will be collected through standardized questionnaires.
A total of 90 patients diagnosed with cervicogenic headache will be randomly assigned to three groups.
Group 1 (n=30) will receive mulligan mobilization therapy three times a week for four weeks (12 sessions total) and a home exercise program.
Group 2 (n=30) will receive myofascial release therapy three times a week for four weeks (12 sessions total), in addition to a home exercise program.
Group 3 (n=30) will receive only a home exercise program three times a week for four weeks (12 sessions total).
All patients will be evaluated at three different time points: before treatment, immediately after treatment is completed, and one month after treatment.
The following assessments will be made during the evaluation process:
To determine the frequency of cervicogenic headaches, patients were given a headache diary.
Head and neck pain in the individuals included in the study was evaluated using the visual analog scale (VAS) before and after treatment.
Participants' functional status was assessed using the headache impact test (HIT-6).
The headache disability inventory/index (HDI) was used to measure the impact of headaches on daily life.
The short form-12 (SF-12) questionnaire was used to assess the patients' quality of life.
Eligibility
Inclusion criteria:
- Individuals aged 18-65
- Having experienced neck or headache for 3 months
- Meeting the diagnostic criteria for cervicogenic headache;
- Unilateral pain
- Reduced range of motion in the neck
- Ipsilateral shoulder discomfort
- Ipsilateral arm discomfort
- Pain that worsens with different neck movements and is painful on palpation
Exclusion criteria:
- Migraine
- Cluster headache
- Cervical radiculopathy
- Entrapment neuropathy
- Myelopathy
- Rheumatoid arthritis
- Undergoing cervical spinal surgery
- Pregnant women
- Those who received physical therapy within 6 months
- Those with a history of major psychiatric illness
- Those with a history of uncontrolled systemic diseases (cardiovascular, pulmonary, hepatic, renal, hematological)
- Those with a history of uncontrolled systemic endocrine diseases (dm, hyperthyroidism)
